Generic Pharmaceuticals Businesses for Sale in Godhra, Gujarat

• Owned a pharmaceutical formulation manufacturing unit specializing in antibiotics and beta-lactam products. • Manufactures tablets, capsules, and dry syrups under regulated pharmaceutical standards. • Product portfolio includes approximately 40 SKUs across therapeutic categories. • Produces formulations under its own brand through an established distributor network. • Also undertakes third-party/job work manufacturing for external pharma companies. • Installed tablet manufacturing capacity of around 1.5 crore tablets per month per shift. • Capsule manufacturing capacity of approximately 50 lakh capsules per month per shift. • Dry syrup production capacity of about 40,000–50,000 bottles per month per shift. • Currently operating at around 5% capacity utilization, leaving substantial headroom for scale-up. • Business activity has reduced over the past two years due to promoter health and age-related constraints. • Sales decline attributed to operational slowdown rather than market or regulatory issues. • Holds valid drug manufacturing license for regulated formulations. • Registered under GST and MSME, ensuring statutory and compliance readiness. Does not have USFDA approval. • Suitable for revival through professional management, marketing tie-ups, or strategic investment.

• Owned a pharmaceutical formulation manufacturing unit specializing in antibiotics and beta-lactam products. • Manufactures tablets, capsules, and dry syrups under regulated pharmaceutical standards. • Product portfolio includes approximately 40 SKUs across therapeutic categories. • Produces formulations under its own brand through an established distributor network. • Also undertakes third-party/job work manufacturing for external pharma companies. • Installed tablet manufacturing capacity of around 1.5 crore tablets per month per shift. • Capsule manufacturing capacity of approximately 50 lakh capsules per month per shift. • Dry syrup production capacity of about 40,000–50,000 bottles per month per shift. • Currently operating at around 5% capacity utilization, leaving substantial headroom for scale-up. • Business activity has reduced over the past two years due to promoter health and age-related constraints. • Sales decline attributed to operational slowdown rather than market or regulatory issues. • Holds valid drug manufacturing license for regulated formulations. • Registered under GST and MSME, ensuring statutory and compliance readiness. Does not have USFDA approval. • Suitable for revival through professional management, marketing tie-ups, or strategic investment.